News

Inovio is co-developing VGX-3400 with Korea-based VGX International. The 30-patient three-dose Phase I study will be conducted in multiple clinical research sites in Korea. A parallel study in

PPD said that the facility expands its global scientific expertise, laboratory capacity and supplies network to meet growing client demand in Europe, Middle East and Africa for these

According to the agreement, the proposed project will encompass a space of approximately 50,000sqmt and mainly focuses on the production, distribution, and research and development of biomedical products.

The trial involved 11 of Synexus’ 26 dedicated recruitment centres across the UK, Europe and South Africa. There were nine US sites also taking part. Of the 565

The project is scheduled to run for 24 months, with the first 12 months committed to experimental research and the second 12 months to selection of a lead

In an earlier clinical study, Ichor’s TriGrid was shown to enhance immune responses to DNA vaccination in human subjects compared to conventional injection. As an automated, push-button electroporation

Valeant is expected to pay Spear a $12m upfront payment and the two companies will share net profits. Valeant will book sales and use its dermatology sales force

Corgenix’ new format offers high-volume testing labs the same performance as the currently available Corgenix rapid assay with improved efficiency and high-volume analysis. Automated microplate Elisa processing from

Merrion Pharma claimed that the enhancers covered by the patent have the ability to enhance oral absorption many fold compared to standard formulations. The technology can therefore be